In the BioHarmony Drug Report Database

"Preview" Icon

Triamcinolone acetonide

Allernaze, Azmacort, Kenalog, Kenalog In Orabase, Nasacort, Nasacort 24 Hour, Nasacort Hfa, Triamcinolone Acetonide, Triesence, Trivaris, Zilretta (triamcinolone acetonide) is a small molecule pharmaceutical. Triamcinolone acetonide was first approved as Allernaze on 1982-01-01. It is used to treat adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, and berylliosis amongst others in the USA. It is known to target glucocorticoid receptor and Ancestral Glucocorticoid Receptor2. Triderm’s patents are valid until 2031-08-04 (FDA).

 

Trade Name

 

Allernaze, Azmacort, Kenalog, Kenalog In Orabase, Nasacort, Nasacort 24 Hour, Nasacort Hfa, Triamcinolone Acetonide, Triesence, Trivaris, Zilretta
 

Common Name

 

triamcinolone acetonide
 

ChEMBL ID

 

CHEMBL1504
 

Indication

 

adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, berylliosis, bronchial spasm, dermatitis herpetiformis, erythema multiforme, facial dermatoses, foot dermatoses, hand dermatoses, hemolytic anemia, hypercalcemia, inflammation, leg dermatoses, multiple sclerosis, nephrotic syndrome, pemphigus, pulmonary tuberculosis, rheumatic diseases, scalp dermatoses, serum sickness, synovitis, systemic lupus erythematosus, thyroiditis, ulcerative colitis, uveitis
 

Drug Class

 

Steroids (not prednisolone derivatives); topical steroids (acetal derivatives)

Image (chem structure or protein)

Triamcinolone acetonide structure rendering